Sandy Solmon is CEO, President and lead investor in Celavie Biosciences LLC, a private company whose mission is to improve lives and restore hope by advancing regenerative stem cell therapies for the treatment of Parkinson’s disease and other central nervous system disorders. A dynamic entrepreneur recognized for innovation, philanthropy, and cutting-edge research, Sandy is also the founder and CEO of Sweet Street Desserts®, the world’s largest manufacturer of frozen gourmet desserts reaching over 70 countries.